Compare ADVB & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADVB | MMLP |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical Specialities | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.2M | 107.8M |
| IPO Year | N/A | 2002 |
| Metric | ADVB | MMLP |
|---|---|---|
| Price | $5.47 | $2.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 200.2K | 11.3K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,653,009,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.26 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $0.19 | $2.21 |
| 52 Week High | $5.82 | $3.85 |
| Indicator | ADVB | MMLP |
|---|---|---|
| Relative Strength Index (RSI) | 83.52 | 40.08 |
| Support Level | $0.36 | $2.56 |
| Resistance Level | $5.75 | $2.74 |
| Average True Range (ATR) | 0.53 | 0.18 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 76.73 | 0.00 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.